1.World Cancer Research Fund and American Institute for Cancer Research (2018) Diet, Nutrition, Physical Activity and Cancer: A Global Perspective. https://www.wcrf.org/dietandcancer.
4.Bozzetti, F (2009) Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 17, 279–284.
5.Burden, ST, Hill, J, Shaffer, JL et al. (2010) Nutritional status of preoperative colorectal cancer patients. J Hum Nutr Diet 23, 402–407.
6.Wheelwright, SJ, Hopkinson, JB, Darlington, AS et al. (2017) Development of the EORTC QLQ-CAX24, A questionnaire for cancer patients With cachexia. J Pain Symptom Manage 53, 232–242.
7.Stein, J, Connor, S, Virgin, G et al. (2016) Anemia and iron deficiency in gastrointestinal and liver conditions. World J Gastroenterol 22, 7908–7925.
8.Cruz-Jentoft, AJ, Bahat, G, Bauer, J et al. (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48, 601.
10.Zhang, X, Pang, L, Sharma, SV et al. (2019) The validity of three malnutrition screening markers among older patients with cancer. BMJ Support Palliat Care. [Epublication ahead of print version]
11.Shaw, C, Fleuret, C, Pickard, JM et al. (2015) Comparison of a novel, simple nutrition screening tool for adult oncology inpatients and the Malnutrition Screening Tool (MST) against the Patient-Generated Subjective Global Assessment (PG-SGA). Support Care Cancer 23, 47–54.
13.Lorton, CM, Griffin, O, Higgins, K et al. (2019) Late referral of cancer patients with malnutrition to dietitians: a prospective study of clinical practice. Support Care Cancer. 28, 2351–2360.
14.Martin, L, Senesse, P, Gioulbasanis, I et al. (2015) Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 33, 90–99.
15.Dunne, RF, Loh, KP, Williams, GR et al. (2019) Cachexia and sarcopenia in older adults with cancer: a comprehensive review. Cancers (Basel) 11 [Epublication 25 November 2019].
16.Fearon, K, Strasser, F, Anker, SD et al. (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12, 489–495.
17.Arends, J, Baracos, V, Bertz, H et al. (2017) ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr 36, 1187–1196.
18.Zhou, T, Wang, B, Liu, H et al. (2018) Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients. J Cachexia Sarcopenia Muscle 9, 306–314.
20.Cruz-Jentoft, AJ, Bahat, G, Bauer, J et al. (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48, 16–31.
21.Ryan, AM, Power, DG, Daly, L et al. (2016) Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc 75, 199–211.
22.Naumann, P, Eberlein, J, Farnia, B et al. (2019) Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation. Cancers (Basel) 11. [Epublication 26 October 2019]
23.Martin, L, Senesse, P, Gioulbasanis, I et al. (2015) Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 33, 90–99.
24.Andreyev, HJN, Norman, AR, Oates, J et al. (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34, 503–509.
25.Peng, P, Hyder, O, Firoozmand, A et al. (2012) Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 16, 1478–1486.
26.Rollins, KE, Tewari, N, Ackner, A et al. (2016) The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. Clin Nutr 35, 1103–1109.
27.Tan, BH, Brammer, K, Randhawa, N et al. (2015) Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol 41, 333–338.
28.Prado, CMM, Lieffers, JR, McCargar, LJ et al. (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9, 629–635.
29.van den Berg, M, Kok, DE, Posthuma, L et al. (2018) Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy. Breast Cancer Res Treat 173, 475–481.
30.Arends, J, Bachmann, P, Baracos, V et al. (2017) ESPEN Guidelines on nutrition in cancer patients. Clin Nutr 36, 11–48.
31.Ferreira, V, Agnihotram, RV, Bergdahl, A et al. (2018) Maximizing patient adherence to prehabilitation: what do the patients say? Support Care Cancer 26, 2717–2723.
33.Silver, JK (2015) Cancer prehabilitation and its role in improving health outcomes and reducing health care costs. Semin Oncol Nurs 31, 13–30.
34.Silver, JK & Baima, J (2013) Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil 92, 715–727.
35.Gillis, C, Fenton, TR, Sajobi, TT et al. (2019) Trimodal prehabilitation for colorectal surgery attenuates post-surgical losses in lean body mass: a pooled analysis of randomized controlled trials. Clin Nutr 38, 1053–1060.
36.Trepanier, M, Minnella, EM, Paradis, T et al. (2019) Improved disease-free survival after prehabilitation for colorectal cancer surgery. Ann Surg 270, 493–501.
37.Gillis, C, Buhler, K, Bresee, L et al. (2018) Effects of nutritional prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: a systematic review and meta-analysis. Gastroenterology 155, 391–410.
38.Baldwin, C & Weekes, CE (2012) Dietary counselling with or without oral nutritional supplements in the management of malnourished patients: a systematic review and meta-analysis of randomised controlled trials. J Hum Nutr Diet 25, 411–426.
39.Ravasco, P, Monteiro-Grillo, I & Camilo, M (2012) Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr 96, 1346–1353.
40.Druml, C, Ballmer, PE, Druml, W et al. (2016) ESPEN Guideline on ethical aspects of artificial nutrition and hydration. Clin Nutr 35, 545–556.
41.Franke, AJ, Iqbal, A, Starr, JS et al. (2017) Management of malignant bowel obstruction associated with GI cancers. J Oncol Pract 13, 426–434.
42.Nikfarjam, M, Wilson, JS & Smith, RC (2017) Diagnosis and management of pancreatic exocrine insufficiency. Med J Aust 207, 161–165.
43.Kim, DJ & Kim, W (2016) Laparoscopy-assisted proximal gastrectomy with double tract anastomosis is beneficial for vitamin B12 and iron absorption. Anticancer Res 36, 4753–4758.
44.Lam, JR, Schneider, JL, Quesenberry, CP et al. (2017) Proton pump inhibitor and histamine-2 receptor antagonist use and iron deficiency. Gastroenterology 152, 821–829.e821.
45.Kornerup, LS, Hvas, CL, Abild, CB et al. (2019) Early changes in vitamin B12 uptake and biomarker status following Roux-en-Y gastric bypass and sleeve gastrectomy. Clin Nutr 38, 906–911.
46.Dawson, DW, Sawers, AH & Sharma, RK (1984) Malabsorption of protein bound vitamin B12. Br Med J (Clin Res Ed) 288, 675–678.
47.Pironi, L, Arends, J, Bozzetti, F et al. (2016) ESPEN Guidelines on chronic intestinal failure in adults. Clin Nutr 35, 247–307.
48.Mountford, CG, Manas, DM & Thompson, NP (2014) A practical approach to the management of high-output stoma. Frontline Gastroenterol 5, 203–207.
49.Parnes, HL, Fung, E & Schiffer, CA (1994) Chemotherapy-induced lactose intolerance in adults. Cancer 74, 1629–1633.
50.Andreyev, J, Ross, P, Donnellan, C et al. (2014) Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol 15, e447–e460.
51.Wedlake, LJ, Shaw, C, Whelan, K et al. (2013) Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy. Aliment Pharmacol Ther 37, 1046–1056.
52.Andreyev, J (2007) Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol 8, 1007–1017.
53.Wedlake, LJ (2018) Nutritional strategies to prevent gastrointestinal toxicity during pelvic radiotherapy. Proc Nutr Soc 77, 357–368.
54.Wedlake, L, Shaw, C, McNair, H et al. (2017) Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy. Am J Clin Nutr 106, 849–857.
55.Haanen, J, Carbonnel, F, Robert, C et al. (2017) Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28, iv119–iv142.
56.Helmink, BA, Khan, MAW, Hermann, A et al. (2019) The microbiome, cancer, and cancer therapy. Nat Med 25, 377–388.
57.Tan, SY, Turner, J, Kerin-Ayres, K et al. (2019) Health concerns of cancer survivors after primary anti-cancer treatment. Support Care Cancer 27, 3739–3747.
58.Aubrey, V, Hon, Y, Shaw, C et al. (2019) Healthy eating interventions in adults living with and beyond colorectal cancer: a systematic review. J Hum Nutr Diet 32, 501–511.
59.Vissers, PAJ, Martucci, RB, Mols, F et al. (2017) The impact of body mass index and waist circumference on health-related quality of life among colorectal cancer survivors: results from the PROFILES registry. Nutr Cancer 69, 1177–1184.
60.van Veen, MR, Mols, F, Bours, MJL et al. (2019) Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention is associated with better health-related quality of life among long-term colorectal cancer survivors: results of the PROFILES registry. Support Care Cancer 27, 4565–4574.